Posted on 4/6/17
Better Buy: AbbVie Inc. vs. GlaxoSmithKline
They're both big, successful drugmakers, but AbbVie (NYSE:ABBV) and GlaxoSmithKline(NYSE:GSK) haven't competed directly against each other all that much in the past. That could potentially change . . .
Posted on 4/6/17
The 3 Most Important Numbers for Pfizer Inc.
It's not hard to be overwhelmed by the sheer volume of numbers included in Pfizer's (NYSE:PFE) financial reports. From the company's accumulated post-retirement benefit obligation to . . .
Posted on 4/6/17
Meadowlands Veterinary Hospital Opens State of the Art Facility
HACKENSACK, N.J.--(BUSINESS WIRE)--Meadowlands Veterinary Hospital receives a warm welcome from the city of Hackensack. On May 1, 2017, a modern, state-of-the-art animal hospital providing both preventative . . .
Posted on 4/5/17
Here's Why The Best Is Yet to Come for Johnson & Johnson
It's become common knowledge that most fund managers fail to outperform the S&P 500 index over the long term, but did you know Johnson & Johnson . . .
Posted on 4/4/17
Johnson & Johnson: Selling And Still Getting Richer
Recently I was paging through a Tony Robbins book and came across the following idea: "You and I know why people don't do well financially… there's . . .
Posted on 4/3/17
Caladrius Biosciences Adds Four Clinical Sites, Including Joslin Diabetes Center
BASKING RIDGE, N.J., April 03, 2017 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (NASDAQ:CLBS), a cell therapy company advancing a select therapeutic development pipeline, announces today that . . .
Posted on 4/3/17
Matinas BioPharma Reports 2016 Financial Results and Provides Corporate Update
BEDMINSTER, N.J., April 03, 2017 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE MKT:MTNB), clinical-stage biopharmaceutical company focused on developing innovative anti-infectives for orphan indications, today . . .
Posted on 4/3/17
Could Pfizer Buy Esperion Therapeutics?
Pfizer Inc. (NYSE:PFE) is back in growth mode, and it has been acquiring smaller companies as part of its effort to boost revenue and profitability. Given . . .
Posted on 4/3/17
Here's How Much Johnson & Johnson Will Probably Raise Its Dividend Next Month
Among healthcare stocks, Johnson & Johnson (NYSE:JNJ) can arguably be described as the cream of the crop. It's one of just two publicly traded companies to . . .
Posted on 4/3/17
3 Big Healthcare Stocks That Wall Street Predicts Will Grow the Fastest
Rapid earnings growth typically translates to higher stock prices. But can big healthcare stocks grow earnings (and presumably share prices) at impressive levels? Wall Street thinks . . .
Posted on 4/3/17
CytoSorbents Announces Pricing of Follow-On Offering
CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its flagship CytoSorb® blood filter to treat deadly inflammation in critically-ill and cardiac surgery patients around . . .
Posted on 3/31/17
Johnson & Johnson: The Senate Probe And Other Risks
JNJ: Herd Holding SteadyAt the beginning of the year, we noted a warning from Credit Suisse (NYSE:CS) analysts about the risk of a herd of investors . . .
Posted on 3/31/17
Akers Biosciences Announces a $2 Million Private Placement
Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), a developer of rapid health information technologies, announces a private placement to raise approximately $2 million. Akers Bio will . . .
Posted on 4/13/17
A Video Conversation with Rick Bunker, Cofounder and CEO of Prescription Advisory Systems and Technology - Part III
Brought to you by Newmark Grubb Knight Frank
Posted on 4/6/17
A Video Conversation with Rick Bunker, Cofounder and CEO of Prescription Advisory Systems and Technology - Part II
Brought to you by Newmark Grubb Knight Frank
Posted on 4/4/17
A Video Conversation with Rick Bunker, Cofounder and CEO of Prescription Advisory Systems and Technology - Part I
Brought to you by Newmark Grubb Knight Frank
Posted on 3/31/17
Select Medical And Riverside Health Enter Joint Venture
Select Medical Corporation, a wholly-owned subsidiary of Select Medical Holdings Corporation (NYSE: SEM), today announced a joint venture agreement with Riverside Health System to operate a . . .
Posted on 3/31/17
CytoSorbents Announces Proposed Offering of Common Stock
CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its flagship CytoSorb® blood filter to treat deadly inflammation in critically-ill and cardiac surgery patients around . . .
Posted on 3/30/17
Worried About Johnson & Johnson's Valuation? Consider This Crazy, Undervalued, 4.2% Yielding Pharmaceutical Stock Instead
When it comes to blue chip dividend growth stocks, they don't get any better than Johnson & Johnson (NYSE:JNJ), whose 54 consecutive years of dividend growth . . .
Posted on 4/24/17
A Video Conversation with Jonathan Maxim, CEO of Vea Fitness - Part III
Brought to you by Newmark Grubb Knight Frank
Posted on 4/14/17
A Video Conversation with Jonathan Maxim, CEO of Vea Fitness - Part II
Brought to you by Newmark Grubb Knight Frank
Posted on 4/11/17
A Video Conversation with Jonathan Maxim, CEO of Vea Fitness - Part I
Brought to you by Newmark Grubb Knight Frank
Posted on 3/29/17
Pivot Physical Therapy Acquires Dynamic Physical Therapy
Pivot Physical Therapy, a leading provider of physical therapy, sports medicine and aquatic therapy services, announced an expansion of its services and locations with the acquisition . . .
Posted on 3/29/17
Why Shares of Immunomedics Inc Are up an Astounding 89% in 2017
Shareholders of small-cap biotech Immunomedics (NASDAQ:IMMU) have had an absolutely blowout 2017 with shares up over 89% in the first 4 months of this year alone. . . .
Posted on 3/28/17
Arno Therapeutics Announces Plan to Deregister its Common Stock
FLEMINGTON, N.J.--(BUSINESS WIRE)--Arno Therapeutics, Inc. (OTCQB:ARNI), a clinical stage biopharmaceutical company focused on the development of therapeutics for cancer and other life threatening diseases, today announced . . .

